Position in NAUT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$712,907
+$297,705 QoQ
Shares Held
381,234
+256.3% QoQ
Ownership
0.300%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 93 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in NAUT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,552,102 across 424 Biotechnology names. NAUT ranks #284 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in NAUT
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $712,907 | 381,234 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $415,202 | 107,011 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $208,671 | 107,011 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $99,571 | 117,836 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $107,638 | 148,467 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $422,797 | 491,054 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $797,698 | 474,821 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $1,446,419 | 507,516 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,161,505 | 496,370 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,511,970 | 514,276 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,596,111 | 533,817 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,688,444 | 534,318 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,071,482 | 535,267 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,232,829 | 445,065 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $798,461 | 443,590 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $944,192 | 445,374 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,209,418 | 449,598 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $609,005 | 140,324 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $747,717 | 144,347 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $556,185 | 90,584 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||